Cargando…

The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung Cancer

BACKGROUND: Circulating tumor DNA (ctDNA) sequence analysis shows great potential in the management of non-small cell lung cancer (NSCLC) and the prediction of drug sensitivity or resistance in many cancers. Here, we drew and compared the somatic mutational profile using ctDNA and tumor tissue seque...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Jun, Jiang, Huihui, Li, Shuqing, Yan, Xiaoxia, Wang, Meng, Li, Na, Zhu, Cuimin, Dong, Hui, Wang, Dongjuan, Xu, Yue, Xie, Hui, Wu, Shouxin, Lou, Jingwei, Zhao, Jiangman, Li, Qingshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902245/ https://www.ncbi.nlm.nih.gov/pubmed/35273907 http://dx.doi.org/10.3389/fonc.2021.751106

Ejemplares similares

Mutational landscape and potential therapeutic targets for sporadic pancreatic neuroendocrine tumors based on target next-generation sequencing
por: Zheng, Kailian, et al.
Publicado: (2021)

Differences in actionable genomic alterations between brain metastases and non-brain metastases in patients with non-small cell lung cancer
por: Nian, Rui, et al.
Publicado: (2022)

Differences of genomic alterations and heavy metals in non-small cell lung cancer with different histological subtypes
por: Mu, Die, et al.
Publicado: (2023)

Microbiological diagnostic performance of metagenomic next-generation sequencing compared with conventional culture for patients with community-acquired pneumonia
por: Lin, Tianlai, et al.
Publicado: (2023)

Corrigendum: Microbiological diagnostic performance of metagenomic next-generation sequencing compared with conventional culture for patients with community-acquired pneumonia
por: Lin, Tianlai, et al.
Publicado: (2023)

Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing
por: Cai, Hui, et al.
Publicado: (2019)

Optimal Strategy for Colorectal Cancer Patients' Diagnosis Based on Circulating Tumor Cells and Circulating Tumor Endothelial Cells by Subtraction Enrichment and Immunostaining-Fluorescence In Situ Hybridization Combining with CEA and CA19-9
por: Luo, Shimu, et al.
Publicado: (2021)

Identification of recurrent and novel mutations by whole-genome sequencing of colorectal tumors from the Han population in Shanghai, eastern China
por: Teng, Hongfei, et al.
Publicado: (2018)

Potential Management of Circulating Tumor DNA as a Biomarker in Triple-Negative Breast Cancer
por: Shang, Mao, et al.
Publicado: (2018)

The Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA
por: Lee, Jessica K., et al.
Publicado: (2022)

Genome‐wide profiling of circulating tumor DNA depicts landscape of copy number alterations in pancreatic cancer with liver metastasis
por: Wei, Tao, et al.
Publicado: (2020)

Characterizing the Genomic Landscape of Brain Glioma With Circulating Tumor DNA From Tumor In Situ Fluid
por: Sheng, Zhiyuan, et al.
Publicado: (2021)

The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies
por: Sawada, Kentaro, et al.
Publicado: (2018)

The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma
por: Mishima, Yuji, et al.
Publicado: (2017)

Clinical Efficiency of Metagenomic Next-Generation Sequencing in Sputum for Pathogen Detection of Patients with Pneumonia According to Disease Severity and Host Immune Status
por: Chang, Can, et al.
Publicado: (2023)

Concordance of Genomic Alterations between Circulating Tumor DNA and Matched Tumor Tissue in Chinese Patients with Breast Cancer
por: Xu, Bing, et al.
Publicado: (2020)

The predicting role of circulating tumor DNA landscape in gastric cancer patients treated with immune checkpoint inhibitors
por: Jin, Ying, et al.
Publicado: (2020)

Detection of genes mutations in cerebrospinal fluid circulating tumor DNA from neoplastic meningitis patients using next generation sequencing
por: Zhao, Yue, et al.
Publicado: (2020)

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
por: Fox, Alan J., et al.
Publicado: (2016)

Targeted Next-Generation Sequencing of Circulating Tumor DNA, Bone Marrow, and Peripheral Blood Mononuclear Cells in Pediatric AML
por: Ruan, Min, et al.
Publicado: (2021)

Impact of liver tumor percutaneous radiofrequency ablation on circulating tumor cells
por: Li, Yang, et al.
Publicado: (2018)

Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas
por: Yang, Chao, et al.
Publicado: (2019)

Genetic landscape of breast cancer and mutation tracking with circulating tumor DNA in Chinese women
por: Wang, Yinghao, et al.
Publicado: (2021)

Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies
por: Ye, Zhenlong, et al.
Publicado: (2018)

Next‐Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma
por: Ikeda, Sadakatsu, et al.
Publicado: (2018)

A novel approach for next‐generation sequencing of circulating tumor cells
por: Yee, Stephanie S., et al.
Publicado: (2016)

The RareCyte® platform for next‐generation analysis of circulating tumor cells
por: Kaldjian, Eric P., et al.
Publicado: (2018)

The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
por: Rice, Alistair, et al.
Publicado: (2019)

Genomic Profiling of Circulating Tumor DNA from Patients with Extensive-Stage Small Cell Lung Cancer Identifies Potentially Actionable Alterations
por: Yang, Jing, et al.
Publicado: (2021)

Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis
por: Yi, Zongbi, et al.
Publicado: (2017)

Whole‐genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer
por: Hai, Luo, et al.
Publicado: (2022)

The prognostic significance of tumor-associated neutrophils and circulating neutrophils in glioblastoma (WHO CNS5 classification)
por: Wang, Xuezhen, et al.
Publicado: (2023)

Pan-cancer analysis of tumor metabolic landscape associated with genomic alterations
por: Choi, Hongyoon, et al.
Publicado: (2018)

Landscape of somatic alterations in large-scale solid tumors from an Asian population
por: Wu, Liqun, et al.
Publicado: (2022)

Detection of ctDNA in the plasma of patients with papillary thyroid carcinoma
por: Li, Huiqiang, et al.
Publicado: (2019)

Targeted Next-Generation Sequencing of Circulating Tumor DNA Mutations among Metastatic Breast Cancer Patients
por: Sun, Min-Ying, et al.
Publicado: (2021)

Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients
por: Lee, Se-Hoon, et al.
Publicado: (2019)

Clinical significance of circulating tumor cells via combined whole exome sequencing in early stage cancer screening: A case report
por: Su, Zijian, et al.
Publicado: (2018)

Validation of a Molecular Diagnostic Test for Circulating Tumor DNA by Next-Gen Sequencing
por: Fernandez, Sandra V., et al.
Publicado: (2023)

Single‐cell next‐generation sequencing of circulating tumor cells in patients with neuroblastoma
por: Kojima, Masato, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1f9jtd29fk14lksiv1u6ffdoqo